Gamma-glutamyl transpeptidase (GGT) is frequently used in clinical practice as a biochemical indicator of liver damage; however, it lacks specificity in determining the underlying cause.10, 11, 12Evidence indicates that elevated GGT levels are linked to a higher risk of liver and cardiovascular disease as well as all-cause mortality.13 The gene discussed is GGTLC1; the disease is cardiovascular disorder.